ATMI doubles bioprocess tech manufacturing capacity
ATMI completes expansion at US bioprocess tech plant days after citing life science business growth as an important part of its second quarter gains.
Archives for July 28, 2010
Hovione grows sales in 09
Consolidated sales at Hovione increased by 15 per cent to $144m (€110m) in fiscal 2009.
Solid diabetes sales drive slight Q3 growth at BD Medical
The medical unit of Becton Dickinson (BD) reported a slight increase in revenues in the third quarter driven by solid sales of diabetes products.
Pharma consolidation and the downstream impact on CROs
Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact on contract research organizations (CRO).
Marina buys Smarticles liposomal delivery system
Marina Biotech has acquired the intellectual property for the Smarticles liposomal-based delivery system from Novosom AG.
Covance op income down as Phase III delays hit margins
Covance has recorded a 29 per cent drop in operating income, despite revenue growth, as cost reduction actions and Phase III delays hit margins.
Chiltern grows market share in FY 2010; plans global expansion
CRO Chiltern International says market share grew in fiscal 2010, citing strengthened industrial relationships and global expansion as drivers.
Demand for discovery services recovering, says Domainex
Demand for drug discovery services is growing again according to Domainex, who predicted that we will see greater pharmaceutical industry reliance on specialist CROs going forward.